While this model allows for controlled evaluation of radiotracer uptake and therapeutic effects, it does not fully recapitulate the tumor microenvironment or metastatic behavior of native CCK2R-expressing cancers such as medullary thyroid carcinoma or pancreatic adenocarcinoma. This evidence concerns the gene CCKBR and pancreatic adenocarcinoma.